Patents by Inventor Anton F. Fliri

Anton F. Fliri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISEASES
    Publication number: 20210251934
    Abstract: Anti-inflammatory compositions that merely treat symptoms of inflammation and not its root causes have frequently been shown to impair healing processes and exacerbate disease. The present disclosure includes novel compositions, combinations and methods of treatment that overcome this shortcoming by down regulating excessive inflammation and by activating cellular functions supporting healing processes.
    Type: Application
    Filed: April 15, 2021
    Publication date: August 19, 2021
    Applicant: SystaMedic Inc.
    Inventors: Anton F. Fliri, Shama Kajiji, Palaniyandi Manivasakam
  • Method of knowledge extraction through data mining
    Patent number: 10242091
    Abstract: The disclosed embodiments relate to data mining methods for determining economically valuable cause effect relationships between objects and properties associated with objects using co-occurrence frequency measurements of semantic terms characterizing observations of properties, effects or behaviors of objects in different environments and using these measurements as object descriptors in calculations determining object similarities.
    Type: Grant
    Filed: August 8, 2014
    Date of Patent: March 26, 2019
    Assignee: SYSTAMEDIC, INC.
    Inventors: Anton F. Fliri, William T. Loging, Robert A. Volkmann
  • Metformin derivatives
    Patent number: 10017529
    Abstract: The present invention relates to novel biguanide derivatives including their pharmaceutically acceptable salts. The invention also relates processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions containing and the uses of such compounds in treating disorders such as diabetes.
    Type: Grant
    Filed: September 16, 2015
    Date of Patent: July 10, 2018
    Assignee: BioPharma Works LLC
    Inventors: Anton F Fliri, Robert A Volkmann
  • METFORMIN DERIVATIVES
    Publication number: 20170247400
    Abstract: The present invention relates to novel biguanide derivatives including their pharmaceutically acceptable salts. The invention also relates processes for the preparation of, intermediates used in the preparation of, pharmaceutical compositions containing and the uses of such compounds in treating disorders such as diabetes.
    Type: Application
    Filed: September 16, 2015
    Publication date: August 31, 2017
    Inventors: Anton F. Fliri, Robert A. Volkmann
  • METHOD OF KNOWLEDGE EXTRACTION THROUGH DATA MINING
    Publication number: 20160259847
    Abstract: The disclosed embodiments relate to data mining methods for determining economically valuable cause effect relationships between objects and properties associated with objects using co-occurrence frequency measurements of semantic terms characterizing observations of properties, effects or behaviors of objects in different environments and using these measurements as object descriptors in calculations determining object similarities.
    Type: Application
    Filed: August 8, 2014
    Publication date: September 8, 2016
    Inventors: Anton F. FLIRI, William T. LOGING, Robert A. VOLKMANN
  • 2,7-substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors
    Patent number: 7220753
    Abstract: Substituted pyrido[1,2-a]pyrazines of general formula I; wherein Ar and Ar1 represent various carbocyclic and heterocyclic aromatic rings; A represents O, S, SO, SO2, CHOH, C?O, or —(CR3R4); and n is 0–2, as well as precursors thereto, are ligands for dopamine receptor subtypes and serotonin (5HT) within the body and are therefore useful in the treatment of disorders of the dopamine and serotonin systems:
    Type: Grant
    Filed: May 24, 2004
    Date of Patent: May 22, 2007
    Assignee: Pfizer Inc.
    Inventors: Kishor A. Desai, Anton F. Fliri, Mark A. Sanner
  • 2,7-Substituted octahydro-1H-pyrido[1,2-a]pyrazine derivatives as ligands for serotonin receptors
    Publication number: 20040214830
    Abstract: Substituted pyrido[1,2-a]pyrazines of general formula I; wherein Ar and Ar1 represent various carbocyclic and heterocyclic aromatic rings; A represents O, S, SO, SO2, CHOH, C═O, or —(CR3R4); and n is 0-2, as well as precursors thereto, are ligands for dopamine receptor subtypes and serotonin (5HT) within the body and are therefore useful in the treatment of disorders of the dopamine and serotonin systems: 1
    Type: Application
    Filed: May 24, 2004
    Publication date: October 28, 2004
    Inventors: Kishor A. Desai, Anton F. Fliri, Mark A. Sanner
  • Dopamine D4 ligands for the treatment of novelty-seeking disorders
    Publication number: 20040116443
    Abstract: The present invention provides a method of treating or preventing a novelty-seeking disorder such as pathological gambling, attention deficit disorder with hyperactivity disorder, substance addiction, drug addiction, alcohol addiction and sex addiction, using a compound which is a dopamine D4 receptor ligand, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 9, 2003
    Publication date: June 17, 2004
    Applicant: Pfizer Inc
    Inventors: Stevin H. Zorn, Mark A. Sanner, Anton F. Fliri, Patricia A. Seymour
  • 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
    Publication number: 20030055061
    Abstract: Substituted pyrido[1,2-a]pyrazines of general formula I; wherein Ar and Ar1 represent various carbocyclic and heterocyclic aromatic rings; A represents O, S, SO, SO2, CHOH, C═O, or —(CR3R4); and n is 0-2, as well as precursors thereto, are ligands for dopamine receptor subtypes and serotonin (5HT) within the body and are therefore useful in the treatment of disorders of the dopamine and serotonin systems: 1
    Type: Application
    Filed: August 7, 2002
    Publication date: March 20, 2003
    Applicant: Pfizer Inc.
    Inventors: Kishor A. Desai, Anton F. Fliri, Mark A. Sanner
  • 2,7-substituted octahydro-1H-pyrido[1,2-A]pyrazine derivatives as ligands for serotonin receptors
    Publication number: 20020132811
    Abstract: Substituted pyrido[1,2-a]pyrazines of general formula I; wherein Ar and Ar1 represent various carbocyclic and heterocyclic aromatic rings; A represents O, S, SO, SO2, CHOH, C═O, or —(CR3R4); and n is 0-2, as well as precursors thereto, are ligands for dopamine receptor subtypes and serotonin (5HT) within the body and are therefore useful in the treatment of disorders of the dopamine and serotonin systems: 1
    Type: Application
    Filed: February 15, 2001
    Publication date: September 19, 2002
    Inventors: Kishor A. Desai, Anton F. Fliri, Mark A. Sanner